ÂÜŔňÂŇÂ×

Dr. Qing Liu, PhD, Co-Founder, has directed research projects both in academia and industry and possesses over 15 years’ experience in scientific project management in a broad range of diseases and cellular models as well as technical expertise in high content screening. Dr. Liu has a long track record of fostering successful R&D collaborations. She has many years’ experience in motor neuron disease research. In her graduate thesis, Dr. Liu established that haplodeficiency of the Survival of Motor Neuron (SMN) protein causes Spinal Muscular Atrophy and later developed high content screens for ALS at Harvard Medical School. She is an expert at business development, licensing, and negotiations in the pharmaceutical area. At USC, within three short years, she has raised over $4M from individuals and foundations to support the mission of the institute.